New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
IM Cannabis Corp.
IMCC
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

5M

Drug Manufacturers - Specialty & Generic

Next Earning date - 11 Nov 2024

5M

Drug Manufacturers - Specialty & Generic

Next Earning date - 11 Nov 2024

2.26USD
Shape0.01 ( 0.44%)
favorite-chart

Relative Strenght

95
favorite-chart

Volume Buzz

37%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

72%

Quote Panel

Shape
Updated October 12, 2024
1W 0.89 % 1M -1.31 % 3M -17.82 % 1Y -40.05 %

Key Metrics

Shape
  • Market Cap

    5.05M


  • Shares Outstanding

    2.23M


  • Share in Float

    1.43M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    2.26


  • Average Volume

    25340


  • Beta

    1.676


  • Range

    1.134-8.1


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.imcannabis.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.09x

P/S Ratio

0.98x

P/B Ratio

2.2

Debt/Equity

-24.0%

Net Margin

$-4.7

EPS

How IMCC compares to sector?

P/E Ratio

Relative Strength

Shape

IMCC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$69M

Shape366%

2025-Revenue

$2.78

Shape-104%

2025-EPS

$18M

Shape-651%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.50
vs -1.40

Q4.22

arrow
arrow

N/A

-1.32
vs -1.50

Q1.23

arrow
arrow

+102%

0.02
vs -1.30

Q2.23

arrow
arrow

N/A

-0.19
vs -2.40

Q3.23

arrow
arrow

N/A

-0.12
vs -0.50

Q4.23

arrow
arrow

N/A

-0.18
vs -1.32

Q1.24

arrow
arrow

N/A

-0.96
vs 0.02

Q2.24

arrow
arrow

N/A

-0.17
vs -0.19

Q3.24

arrow
arrow

N/A

-1.41
vs -0.12

Q4.24

arrow
arrow

N/A

-1.21
vs -0.18

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-2%

14.2M  vs 14.4M

Q4.22

arrow
arrow

-28%

14.5M  vs 20M

Q1.23

arrow
arrow

-44%

13.2M  vs 23.6M

Q2.23

arrow
arrow

-45%

13.2M  vs 23.8M

Q3.23

arrow
arrow

+169%

38.1M  vs 14.2M

Q4.23

arrow
arrow

-26%

10.7M  vs 14.5M

Q1.24

arrow
arrow

-8%

12.1M  vs 13.2M

Q2.24

arrow
arrow

+12%

14.8M  vs 13.2M

Q3.24

arrow
arrow

-59%

15.6M  vs 38.1M

Q4.24

arrow
arrow

+48%

15.8M  vs 10.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vs -0.11

Q4.22

arrow
arrow

-43%

-0.43
vs -0.08

Q1.23

arrow
arrow

+0%

0
vs -0.43

Q2.23

arrow
arrow

-18%

-0.18
vs 0

Q3.23

arrow
arrow

-32%

-0.32
vs -0.18

Q4.23

arrow
arrow

-23%

-0.23
vs -0.32

Q1.24

arrow
arrow

-59%

-0.59
vs -0.23

Q2.24

arrow
arrow

-43%

-0.43
vs -0.59

Institutionnal OwnershipShape

status-upQoQ

Q1.21

arrow
arrow

9

9
vs NA

NA

Q2.21

arrow
arrow

17

17
vs 9

89%

Q3.21

arrow
arrow

23

23
vs 17

35%

Q4.21

arrow
arrow

37

37
vs 23

61%

Q1.22

arrow
arrow

29

29
vs 37

-22%

Q2.22

arrow
arrow

21

21
vs 29

-28%

Q3.22

arrow
arrow

20

20
vs 21

-5%

Q4.22

arrow
arrow

1

1
vs 20

-95%

Earnings Growth

Latest News